nodes	percent_of_prediction	percent_of_DWPC	metapath
Piroxicam—SLC22A11—Furosemide—dilated cardiomyopathy	0.357	0.367	CbGbCtD
Piroxicam—SLC22A8—Furosemide—dilated cardiomyopathy	0.208	0.214	CbGbCtD
Piroxicam—SLC22A6—Furosemide—dilated cardiomyopathy	0.145	0.149	CbGbCtD
Piroxicam—CYP2C8—Spironolactone—dilated cardiomyopathy	0.139	0.143	CbGbCtD
Piroxicam—ALB—Furosemide—dilated cardiomyopathy	0.123	0.127	CbGbCtD
Piroxicam—Oxcarbazepine—SCN5A—dilated cardiomyopathy	0.00506	1	CrCbGaD
Piroxicam—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00346	0.158	CbGpPWpGaD
Piroxicam—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00264	0.12	CbGpPWpGaD
Piroxicam—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0022	0.101	CbGpPWpGaD
Piroxicam—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.000876	0.04	CbGpPWpGaD
Piroxicam—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000694	0.0317	CbGpPWpGaD
Piroxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000529	0.0241	CbGpPWpGaD
Piroxicam—CYP2C9—cardial valve—dilated cardiomyopathy	0.00048	0.736	CbGeAlD
Piroxicam—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000441	0.0201	CbGpPWpGaD
Piroxicam—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00032	0.0146	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000315	0.0144	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000275	0.0126	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000262	0.012	CbGpPWpGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.000241	0.011	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00024	0.011	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000239	0.0109	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000227	0.0104	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000203	0.00926	CbGpPWpGaD
Piroxicam—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000202	0.00923	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000201	0.00915	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000193	0.00882	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000174	0.00796	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000167	0.00763	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000165	0.00753	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000165	0.00751	CbGpPWpGaD
Piroxicam—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000161	0.00733	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00016	0.00731	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00016	0.00731	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.000156	0.00712	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000149	0.00679	CbGpPWpGaD
Piroxicam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000148	0.00677	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000138	0.00632	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000135	0.00616	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000134	0.00612	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.000131	0.00598	CbGpPWpGaD
Piroxicam—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000131	0.00596	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000129	0.00587	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000126	0.00573	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000125	0.00571	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000122	0.00557	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000122	0.00557	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000122	0.00557	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000118	0.00537	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000114	0.00518	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000109	0.00498	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000107	0.00489	CbGpPWpGaD
Piroxicam—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000106	0.00485	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000106	0.00483	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000105	0.00478	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000104	0.00477	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000104	0.00476	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000104	0.00475	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000102	0.00466	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000102	0.00465	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000102	0.00465	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.94e-05	0.00454	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	9.73e-05	0.00444	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.48e-05	0.00432	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.34e-05	0.00426	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	9e-05	0.00411	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	8.69e-05	0.00397	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	8.66e-05	0.00395	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	8.28e-05	0.00378	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	8.27e-05	0.00377	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.09e-05	0.00369	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.04e-05	0.00367	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.6e-05	0.00347	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.56e-05	0.00345	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	7.42e-05	0.00338	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	7.16e-05	0.00327	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	6.82e-05	0.00311	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.58e-05	0.003	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	6.38e-05	0.00291	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TTN—dilated cardiomyopathy	6.29e-05	0.00287	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.19e-05	0.00282	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	5.57e-05	0.00254	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	5.46e-05	0.00249	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.45e-05	0.00249	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.34e-05	0.00244	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.3e-05	0.00242	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.3e-05	0.00242	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	5.24e-05	0.00239	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.15e-05	0.00235	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	5.11e-05	0.00233	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	5.08e-05	0.00232	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	5.04e-05	0.0023	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.93e-05	0.00225	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	4.74e-05	0.00216	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—VCL—dilated cardiomyopathy	4.64e-05	0.00212	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	4.43e-05	0.00202	CbGpPWpGaD
Piroxicam—ALB—heart—dilated cardiomyopathy	4.25e-05	0.0652	CbGeAlD
Piroxicam—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	4.16e-05	0.0019	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	4.14e-05	0.00189	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.06e-05	0.00185	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	3.85e-05	0.00176	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	3.76e-05	0.00172	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	3.63e-05	0.00166	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	3.6e-05	0.00164	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	3.58e-05	0.00163	CbGpPWpGaD
Piroxicam—PTGS1—myocardium—dilated cardiomyopathy	3.47e-05	0.0532	CbGeAlD
Piroxicam—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	3.39e-05	0.00155	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	3.37e-05	0.00154	CbGpPWpGaD
Piroxicam—ALB—Metabolism—TAZ—dilated cardiomyopathy	3.37e-05	0.00154	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.34e-05	0.00153	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	3.29e-05	0.0015	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.25e-05	0.00148	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	3.21e-05	0.00147	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	3.06e-05	0.0014	CbGpPWpGaD
Piroxicam—ALB—Metabolism—SDHA—dilated cardiomyopathy	3.04e-05	0.00139	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.93e-05	0.00134	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.89e-05	0.00132	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.82e-05	0.00129	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.76e-05	0.00126	CbGpPWpGaD
Piroxicam—CYP2C9—heart—dilated cardiomyopathy	2.65e-05	0.0407	CbGeAlD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.54e-05	0.00116	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.49e-05	0.00114	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.48e-05	0.00113	CbGpPWpGaD
Piroxicam—PTGS1—heart—dilated cardiomyopathy	2.42e-05	0.0372	CbGeAlD
Piroxicam—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	2.41e-05	0.0011	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	2.33e-05	0.00106	CbGpPWpGaD
Piroxicam—PTGS2—heart—dilated cardiomyopathy	2.31e-05	0.0355	CbGeAlD
Piroxicam—PTGS2—Disease—NPPA—dilated cardiomyopathy	2.3e-05	0.00105	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.3e-05	0.00105	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.29e-05	0.00105	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.24e-05	0.00102	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PSEN2—dilated cardiomyopathy	2.23e-05	0.00102	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.18e-05	0.000997	CbGpPWpGaD
Piroxicam—PTGS1—cardiac atrium—dilated cardiomyopathy	2.07e-05	0.0318	CbGeAlD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.07e-05	0.000943	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.01e-05	0.000919	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.99e-05	0.000907	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—RAC1—dilated cardiomyopathy	1.87e-05	0.000854	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.87e-05	0.000852	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.86e-05	0.000847	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.82e-05	0.00083	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.81e-05	0.000825	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.64e-05	0.000747	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.63e-05	0.000743	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.52e-05	0.000694	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.48e-05	0.000676	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.33e-05	0.000608	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	1.29e-05	0.000588	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CD36—dilated cardiomyopathy	1.25e-05	0.000572	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.24e-05	0.000566	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—AGT—dilated cardiomyopathy	1.13e-05	0.000515	CbGpPWpGaD
Piroxicam—PTGS2—Disease—RAC1—dilated cardiomyopathy	1.12e-05	0.000511	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.07e-05	0.00049	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	1.02e-05	0.000467	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CD36—dilated cardiomyopathy	9.95e-06	0.000454	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—AGT—dilated cardiomyopathy	8.96e-06	0.000409	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	8.32e-06	0.00038	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GPX1—dilated cardiomyopathy	8.27e-06	0.000377	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	8.1e-06	0.00037	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CD36—dilated cardiomyopathy	8.05e-06	0.000368	CbGpPWpGaD
Piroxicam—PTGS2—Disease—RAF1—dilated cardiomyopathy	7.43e-06	0.000339	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	7.29e-06	0.000333	CbGpPWpGaD
Piroxicam—ALB—Metabolism—AGT—dilated cardiomyopathy	7.25e-06	0.000331	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	6.77e-06	0.000309	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	6.59e-06	0.000301	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.94e-06	0.000271	CbGpPWpGaD
Piroxicam—PTGS2—Disease—EGFR—dilated cardiomyopathy	5.09e-06	0.000232	CbGpPWpGaD
